Study S000894
The Effects of Semaglutide on Modulation of Taste Sensitivity, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Responses in Women With PCOS and Obesity: a Randomized, Single-blind, Placebo-controlled Clinical Trial
Registration
Registered primary outcomes
- to investigate the effect of semaglutide on taste perception as change in taste sensitivity detected by chemical gustometry evaluated with "Taste strips" test [Changes in taste perception from baseline up to the end of 12th week.]
- CO-PRIMARY END-POINT : to investigate alteration of transcriptomic profile of human tongue tissue as changes in expression level from baseline to follow up after 12 weeks of treatment, measured by RNA sequencing [Change in transcriptomic profile from baseline up to the end of 12th week.]
Linked records (2)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
| Record | Title | Year | Design | Identifiers | Link basis |
|---|---|---|---|---|---|
| R0055574 | 6468 Once-Weekly Semaglutide and Taste Perception in Women with Obesity M Jensterle Sever, Journal of the Endocrine Society | 2024 | Randomized trial | DOI | cites ClinicalTrials.gov:NCT04263415 |
| R0015032 | Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial. Jensterle M, Trials | 2021 | Protocol | PMID 34281590DOI | cites ClinicalTrials.gov:NCT04263415; registry reference DERIVED:34281590 |